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ABSTRACT
A study investigated the use of Anti-Mullerian hormone (AMH) and/or follicle counts as
a predictor of subsequent superovulatory response and embryo production in 79 beef cows.
Before initiation of superovulation, ultrasonography was used to scan the ovaries of each donor
cow to record the number of 3 to 5 mm follicles present, and a blood sample was collected for
measure of serum AMH. At the time of embryo collection, the ovaries of donor cows were
palpated to estimate the number of corpora lutea (CL) present on each ovary. Recovered
embryos were evaluated for stage of development and morphological quality. Across cows,
serum AMH ranged from 0.013 to 0.898 ng/mL, with a mean of 0.293 ng/mL. The distribution
of AMH concentrations was divided into quartiles (AMH Q1 through Q4, with Q1 the lowest
and Q4 the highest, ng/mL) for analysis. Donor cows in AMH Q4 had a greater (P < 0.001)
number of 3 to 5 mm follicles at the start of superovulation than did donors in either Q1 or Q2.
At embryo collection, cows in AMH Q3 and 4 had more (P < 0.001) palpable CL than cows in
AMH Q1. The mean number of embryos recovered from donor cows in AMH Q4 was greater (P
< 0.001) than those recovered from cows in either AMH Q1 or 2, but similar to that of AMH Q3.
The percentage of recovered embryos classified as transferrable, degenerate or unfertilized were
similar (P  0.275) across AMH quartiles. Analysis indicated that AMH was positively
correlated (P < 0.001) with mean follicles (r = 0.458), CL (r = 0.452) and embryos recovered (r =
0.430). In order to determine if follicle counts at the start of superovulation might also be
predictive of subsequent superovulatory response, the distribution of follicle counts were divided
into quartiles (F Q1 through Q4, with Q1 the lowest and Q4 the highest) for analysis. Donor
cows with higher follicle counts (F Q3 and 4) at the start of superovulation had more (P < 0.001)
palpable CL at embryo collection than donor cows in F Q1 or 2. More (P < 0.001) embryos were

recovered from cows with the highest follicle counts (F Q4) as compared with cows having
lower (F Q1 and 2) follicle counts. The percentage of transferable embryos and unfertilized ova
were similar (P  0.688) across follicle count quartiles. As was noted for AMH, mean number of
follicles at the start of superovulation was positively correlated (P < 0.001) with mean CL (r =
0.556) and mean embryos (r = 0.423) but not percentage of viable or degenerate embryos, or
unfertilized oocytes (P  0.153). In conclusion, results confirm that relative AMH concentration
was positively correlated with number of small antral follicles in the ovaries of cows and might
be used to either predict superovulatory response or possibly adjust superovulatory regimen to
improve superovulatory response. Antral follicle counts at the initiation of superovulatory
treatments might be a more practical alternative to AMH for predicting superovulatory response.
Further study is needed to determine the effectiveness of using either AMH concentration or
follicle counts to adjust superovulatory regimens for improved response.
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CHAPTER 1: LITERATURE REVIEW
Sexual Differentiation and Discovery of Anti-Mullerian Hormone
German anatomist and physiologist, Johanness Muller (1801-1858) is credited with the
first description of the Mullerian ducts, the anlagen of the uterus, oviducts and anterior vagina.
The Wolffian ducts (named for German anatomist Caspar F. Wolff; 1733-1794) are male
counterparts of the Mullerian ducts and differentiate into the vas deferens, epididymides and
seminal vesicles (Teixeira et al., 2001). In females, the Wolffian ducts degenerate, giving rise
only to the Mullerian ducts whereas in males, two processes must occur. First the Wolffian ducts
must be stimulated and maintained to differentiate into the male reproductive tract by
testosterone produced by Leydig cells in the testes. Secondly, the Mullerian ducts regress due to
the action of Anti-Mullerian hormone (AMH; Munsterberg and Lovell-Badge, 1991).
Anti-Mullerian hormone is a homodimeric disulfide-linked glycoprotein in the
transforming growth factor beta family, with a molecular weight of 140 kDa (La Marca and
Volpe, 2006). Alfred Jost is credited for discovering AMH in the 1940s. By performing in vivo
embryonic experiments in rabbits, Jost demonstrated the existence of what he called Mullerian
"hormone inhibitrice" or “Mullerian inhibitor” (Teixeira et al., 2001). Anti-Mullerian hormone
is responsible for establishing embryonic sexual dimorphism based on presence or absence of the
testis-determining factor (TDF), also known as sex-determining region Y (SRY) (Tüttelmann et
al., 2009). In the presence of a Y chromosome, the genital ridge will arise on the mesonephros
and a testis will develop due to the action of the TDF. Leydig cells of the developing testes
produce testosterone to maintain and develop the Wolffian ducts while AMH produced by
Sertoli cells causes regression of the Mullerian ducts. If the Y chromosome is absent, a default
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pathway is followed resulting in development of an ovary (Munsterberg and Lovell-Badge,
1991).
In cattle, freemartins are an example of abnormal sexual differentiation that occurs when
a female is born twin to a male calf. During early gestation, the placentae of developing male
and female fetuses fuse, resulting in common fetal circulation. Testosterone and AMH produced
by the developing male testes enters female circulation to inhibit female reproductive tract
development. Freemartins are first recognizable about 49 days of gestation, when the upper part
of the Mullerian ducts regress and the presumptive ovaries stop growing (Jost et al., 1972). After
birth, the female ovaries are often stunted and contain sterile seminiferous tubules (Jost et al.,
1972). Portions of the Wolffian ducts, including the seminal vesicles and epididymis are present
but no change is noted in the external genitalia (Jost et al., 1972).
Role of Anti-Mullerian Hormone in Females
While the role of AMH in male sexual differentiation is well known, more recent studies
have demonstrated that granulosa cells within follicles in the ovaries of females also produce
AMH. In the male, a six week old fetal testis has no AMH expression, but AMH is expressed by
eight and one-half weeks of development (Rajpert-De Meyts et al., 1999). Expression of AMH
in the male increases after birth, then gradually declines until puberty. In the female, AMH
expression is not detected in granulosa cells of pre-antral follicles in fetal ovaries until 36 weeks
gestation (Rajpert-De Meyts et al., 1999). Production of AMH by granulosa cells continues until
the end of ovarian activity at reproductive senescence (Josso et al., 2001). While antral follicles
2 to 5 mm in diameter produce more AMH due to high granulosa cell numbers, smaller follicles
also contribute to serum AMH concentrations based on their larger numbers within ovaries (Van
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Rooij et al., 2002). Therefore, the relative contribution of the different follicle stages to the final
serum AMH concentration is unclear.
Anti-Mullerian hormone functions to regulate the recruitment of primordial follicles into
the pool of growing follicles (i.e, folliculogenesis) and regulate the responsiveness of follicles to
follicle stimulating hormone (FSH; Visser et al., 2006). Primordial follicles (resting stage) are
formed within the ovaries of developing females during the first trimester of gestation. At birth,
the number of follicles present in the ovaries of heifer calves is reported to range from 10,000 to
350,000 (Erickson, 1966). Studies utilizing AMH-deficient mice as a model show that such
mice are fertile, but delete the number of primordial follicles in their ovaries earlier in life than
control mice (Durlinger et al., 1999). Anti-Mullerian hormone limits the number of primordial
follicles entering folliculogenesis at any given time by reducing their responsiveness to FSH
(Visser et al., 2006). As antral-stage follicles grow beyond 4 to 5 mm in diameter, their AMH
production declines, resulting in increased responsiveness to FSH. The antral follicle within the
pool of growing follicles with greatest responsiveness to FSH is likely the one selected to
become the dominant follicle.
Anti-Mullerian Hormone as a Predictor of Follicular Population and Fertility
Anti-Mullerian hormone is highly correlated with the total number of healthy follicles
within the ovaries (Visser et al., 2006). If AMH is to be used to characterize the follicular
population within ovaries, the question arises as to when and how often AMH should be
measured to accurately reflect that follicular population. Ireland et al. (2008) used
ultrasonography to characterize beef heifers as having low, intermediate or high antral follicle
counts, then measured AMH daily, from day 6 of the estrous cycle through day 2 of the
subsequent cycle. Although AMH varied somewhat by day of estrous cycle, all measures of
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AMH correctly characterized heifers into low, intermediate and high categories, regardless of
day of the cycle when AMH was measured. Therefore, a single measurement of AMH
concentration in serum can be used to determine the size of the ovarian reserve of follicles. After
measure of AMH from day 6 through day 2 of the subsequent estrous cycle, Ireland et al. (2008)
surgically removed one ovary from each heifer characterized as having either high and low antral
follicle counts for further histological analysis. Heifers characterized as having low follicle
counts were found to have 60% smaller ovaries and 80% fewer morphologically healthy follicles
and oocytes, suggesting a link between follicle number and fertility.
Low concentrations of progesterone in circulation are associated with higher embryonic
mortality in cattle (Mann and Lamming, 1999). Both beef and dairy cows characterized as
having low antral follicle counts also have progesterone concentrations that are 40 to 50% lower
during the luteal phase of the estrous cycle than similar cows having high antral follicular counts
(Jimenez-Krassel et al., 2009). This study also reported that within animals, progesterone
concentrations were similar (i.e., repeatable for cows with low versus high follicle counts) over 3
estrous cycles. In addition to impaired luteal function, there is evidence that oocyte quality is
compromised in cows with low follicular counts. Ireland et al. (2009) recovered the ovaries
from cattle with either high or low antral follicle counts on day 2 to 3 of the estrous cycle, and
recovered the cumulus cells from the 3 largest follicles on each ovary. Measure of cathepsin B
and S mRNA in cumulus cells found a 2 and 6 fold increase, respectively, in these mRNA
transcripts in cumulus cells from animals with low follicle counts. Both of these mRNA
transcripts are associated with reduced development of embryos to the blastocyst stage in vitro
(Bettegowda et al., 2008).
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Anti-Mullerian hormone has also been classified as the best predictive marker of the
ovarian response to a stimulatory treatment, as defined by the number of oocytes collected in
assisted reproductive technologies (ART) (Muttukrishna et al., 2004; Muttukrishna et al., 2005).
Muttukrishna et al. (2004) collected blood samples on 69 women who were over the age of 38;
17 of which were canceled due to poor ovarian response. Blood samples were collected on day 5
or 6 of the follicular phase to investigate whether AMH could be a helpful tool in predicting the
ovarian response to gonadotropin treatment. The average AMH concentration in blood was
found to be lower for the canceled group than the completed group. Therefore, AMH was
characterized as a predictive marker for the ovarian response in patients undergoing ovarian
stimulation. To follow up study Muttukrishna et al. (2005) evaluated the relationship of AMH,
inhibin B and antral follicle count (AFC) to ovarian response in women undergoing ovarian
stimulation for in vitro fertilization (IVF). Ultrasonography was performed on day 3 to
determine AFC and blood samples were collected for AMH, and inhibin B concentrations.
Measurements of inhibin B and AFC were found to be positively associated with the number of
oocytes collected, while AMH was the best predictor of patients who responded poorly to
superovulatory treatment.
In addition to studies in humans, research has been done in livestock species regarding
the potential use of AMH in assisted reproductive technologies and multiple ovulation and
embryo transfer (MOET) programs. Monniaux et al. (2011) conducted an experiment using
goats to establish any seasonal variation in AMH and AFC (during the breeding season, at the
end of breeding season, and at the end of anestrus) and determine their effects on embryo
production. Plasma was recovered for assay of AMH at three different time periods: before first
FSH injection (T0), at time of insemination (TI) and at time of embryo collection (TEC) during
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each season period. Plasma recovered during the spring (February to April) were found to
increase in AMH concentration, while plasma recovered in the fall (August to October) slightly
decreased during the last two weeks. Anti-Mullerian hormone at (T0) was found to have a high
positive correlation with the number of embryos collected in all three season periods, with AMH
expression highest in 1 to 5 mm follicles and expression practically lost in follicles greater than 8
mm. The AMH concentration at T0 was found to be a predictive marker for the number of
embryos recovered, regardless of the season. While 1 to 5 mm follicles were found to be highly
correlated with the total number of corpora lutea (CL) and embryos recovered, regardless of the
season (Monniaux et al., 2011).
Superovulation and embryo transfer
The first successful embryo transfer (ET) was reported in 1890, when Walter Heape
transferred two 4-cell Angora rabbit embryos into a bred Belgian doe that subsequently gave
birth to four Belgian and two Angora offspring (Heape, 1891). It was not until 1950 that the first
live ET calf was produced, by surgical transfer of an in vivo produced embryo recovered at
slaughter (Willet et al., 1951). During the mid 1970s, development and/or refinement of nonsurgical embryo collection and transfer techniques led to commercialization of the embryo
transfer industry. According to the December 2013 report of the international embryo transfer
society (IETS) Data Retrieval Committee (http://www.iets.org/comm_data.asp), a total of
699,586 in vivo derived and 443,533 in vitro derived embryos were produced and available for
transfer globally in 2013.
Over the past 4 decades, numerous research efforts have been directed toward improving
superovulation regimens in cattle. Improvement has been made in the porcine FSH product most
commonly used for superovulation. For several years, a crude porcine anterior pituitary extract
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was used which contained varying amounts of both FSH and luteinizing hormone (LH).
Variation in superovulatory response was attributed to batch-to-batch content of LH (Murphy et
al., 1984). A study comparing the superovulatory response with a constant amount of FSH but
varying amounts of LH reported that the number of fertilized and transferrable embryos
recovered increased with decreasing LH content (Chupin et al., 1984). In fact, a later study
(Looney et al., 1988) reported good superovulatory responses, with a high rate of fertilization
and viable embryo production, when using recombinant bovine FSH alone (no exogenous LH)
for superovulation of donor cows. A study comparing the superovulatory response of FSH
preparations varying from pure FSH to a 1 to 1 ratio of LH to FSH indicated acceptable
responses (total, fertilized and transferrable embryo production) occurred when the LH content
was no more than 15 to 20% (Willmott et al., 1990). Currently, Follitropin-V is a widely used,
purified FSH product for superovulation of cows that contains 16% LH.
For many years, superovulation was based on the donor's natural estrous cycle, with
superovulatory treatment initiated between day 8 and 12 of the cycle. This required that donors
be successfully synchronized within a few days of each other before superovulation could begin.
A significant improvement in scheduling of donors occurred with the incorporation of
supplemental progesterone in the superovulatory regimen. Goulding et al. (1994) compared the
superovulatory response of beef heifers where superovulation treatment was initiated mid cycle
versus after insertion of a progesterone-releasing intravaginal device (PRID) at varying times of
the cycle. Results of the study showed that supplemental progesterone could be used to initiate
superovulation at any stage of the cycle, simplifying scheduling of embryo donors. To avoid the
need to synchronize the natural cycle of donors, controlled internal drug release (CIDR)
progesterone inserts are currently used, with superovulation initiated 7 days after CIDR insertion.
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The presence of a dominant follicle at the start of superovulation is known to reduce
superovulatory response, due to suppression of the stimulatory effects of FSH by inhibin. This
inhibition can be avoided by initiation of superovulation at follicular wave emergence. A
method of timing initiation of superovulatory treatment with follicular wave emergence is to
aspirate the 2 largest follicles present on the ovaries (i.e., follicle ablation) and initiate
superovulatory treatment 2 days later (Baracaldo et al., 2000). However, this method requires
transvaginal ultrasound-guided aspiration equipment that most ET practitioners do not have
access or training to use. A procedure that has been shown to be as effective as follicle ablation
is the use of steroid hormones to induce regression of the dominant follicle and emergence of a
new follicular wave. With this method, embryo donors receive an injection of estradiol and
progesterone in conjunction with a CIDR progesterone insert on day 0. On day 4, superovulation
is initiated at follicular wave emergence (Baracaldo et al., 2000). In a superovulation protocol
where a CIDR is inserted in conjunction with estradiol treatment on day 0 and FSH injections
started on day 4, Bo et al. (2006) reported that delaying CIDR removal by 12 hours (from day
6.5 to day 7) and injecting gonadotropin-releasing hormone (GnRH) 12 to 24 hours after CIDR
removal resulted in both synchronized ovulation and an increase in mean embryo produced. An
advantage of the protocol was that it allowed for fixed-time insemination of donors, thus
eliminating the need to detect estrus. The use of estradiol alone or in combination and
progesterone to control follicular wave emergence is very effective. However, the use of steroids
is prohibited in many countries.
While numerous improvements have been made in superovulatory regimens over the
years, embryo production per donor has shown little progress. In 1994, members of the
American Embryo Transfer Association (AETA) reported a mean number of embryos recovered
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per donor of 5.5. Twenty years later, AETA and Canadian Embryo Transfer Association
members reported a range of 5 to 7 embryos recovered per donor (Hasler, 2010). Donor
response to gonadotropin treatment remains highly variable between individuals and difficult to
predict (Rico et al., 2009). A major source of variability is the status of ovarian follicles at
initiation of FSH treatment (Rico et al., 2009). Cows with few growing, small antral follicles
subsequently have a poor ovulatory response to FSH treatment (Monniaux et al., 1983;
Kawamata, 1994; Cushman et al., 1999). Recent studies indicate that AMH could be an
endocrine marker to help predict superovulatory responses to treatments administered to cows
for embryo production.
Monniaux et al. (2010) reported on a study where plasma was collected for measure of
AMH before the start of superovulation treatment of Holstein cows, to determine if AMH had
the potential to predict the number of embryos produced by individual cows. Between cows,
AMH was found to range from 0.0011 to 0.5312 ng/mL. Cows with AMH greater than 0.2
ng/mL produced more embryos than cows having either 0.1 to 0.2 ng/mL or less than 0.1 ng/mL
of AMH. In a recent study, Souza et al. (2015) reported that high producing dairy cows with
AMH concentrations ranging from 0.1844 to 0.3733 ng/mL had a higher superovulatory
response and more embryos recovered (14 versus 5 to 7) than cows with lower circulating AMH.
These studies indicate that measure of AMH in blood of potential donor cows would be of value
in identifying donors more likely to have a good response to superovulation. Prior knowledge of
how a potential donor might respond to superovulatory treatment could also allow for
modification of superovulatory protocols to improve their effectiveness.
Conclusion
After approximately 4 decades of practice, the bovine ET industry is well established in
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many countries. Through numerous research efforts, improvements have been made in
superovulatory products and regimens. Donor and recipient management have been simplified.
Despite improvements, extreme donor-to-donor variability in superovulatory response remains a
concern. Embryo production per donor has not changed in the past 20 years. The ability to
predict superovulatory response and adjust regimens accordingly would be of great benefit to the
ET industry. Research indicates that a single measure of circulating AMH accurately reflects the
population of follicles within the ovaries. Animals with a greater number of follicles are those
found to respond well to superovulatory treatments. Therefore, a study is proposed to investigate
the use of AMH and/or follicle counts as a predictor of subsequent superovulatory response and
embryo production in beef cows. In most instances, the client rather than the ET practitioner
selects the potential embryo donor. If either or both AMH and antral follicle counts can
accurately predict superovulatory responses, then protocols might be adjusted to improve the
probability of success, regardless of the donor's potential.
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CHAPTER 2: ANTI-MULLERIAN HORMONE AS A PREDICTIVE ENDOCRINE
MARKER FOR SUPEROVULATORY RESPONSE AND EMBRYO PRODUCTION IN
BEEF CATTLE
Abstract
A study investigated the use of Anti-Mullerian hormone (AMH) and/or follicle counts as
a predictor of subsequent superovulatory response and embryo production in 79 beef cows.
Before initiation of superovulation, ultrasonography was used to scan the ovaries of each donor
cow to record the number of 3 to 5 mm follicles present, and a blood sample was collected for
measure of serum AMH. At the time of embryo collection, the ovaries of donor cows were
palpated to estimate the number of corpora lutea (CL) present on each ovary. Recovered
embryos were evaluated for stage of development and morphological quality. Across cows,
serum AMH ranged from 0.013 to 0.898 ng/mL, with a mean of 0.293 ng/mL. The distribution
of AMH concentrations was divided into quartiles (AMH Q1 through Q4, with Q1 the lowest
and Q4 the highest, ng/mL) for analysis. Donor cows in AMH Q4 had a greater (P < 0.001)
number of 3 to 5 mm follicles at the start of superovulation than did donors in either Q1 or Q2.
At embryo collection, cows in AMH Q3 and 4 had more (P < 0.001) palpable CL than cows in
AMH Q1. The mean number of embryos recovered from donor cows in AMH Q4 was greater (P
< 0.001) than those recovered from cows in either AMH Q1 or 2, but similar to that of AMH Q3.
The percentage of recovered embryos classified as transferrable, degenerate or unfertilized were
similar (P  0.275) across AMH quartiles. Analysis indicated that AMH was positively
correlated (P < 0.001) with mean follicles (r = 0.458), CL (r = 0.452) and embryos recovered (r =
0.430). In order to determine if follicle counts at the start of superovulation might also be
predictive of subsequent superovulatory response, the distribution of follicle counts were divided
into quartiles (F Q1 through Q4, with Q1 the lowest and Q4 the highest) for analysis. Donor
cows with higher follicle counts (F Q3 and 4) at the start of superovulation had more (P < 0.001)
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palpable CL at embryo collection than donor cows in F Q1 or 2. More (P < 0.001) embryos were
recovered from cows with the highest follicle counts (F Q4) as compared with cows having
lower (F Q1 and 2) follicle counts. The percentage of transferable embryos and unfertilized ova
were similar (P  0.688) across follicle count quartiles. As was noted for AMH, mean number of
follicles at the start of superovulation was positively correlated (P < 0.001) with mean CL (r =
0.556) and mean embryos (r = 0.423) but not percentage of viable or degenerate embryos, or
unfertilized oocytes (P  0.153). In conclusion, results confirm that relative AMH concentration
was positively correlated with number of small antral follicles in the ovaries of cows and might
be used to either predict superovulatory response or possibly adjust superovulatory regimen to
improve superovulatory response. Antral follicle counts at the initiation of superovulatory
treatments might be a more practical alternative to AMH for predicting superovulatory response.
Further study is needed to determine the effectiveness of using either AMH concentration or
follicle counts to adjust superovulatory regimens for improved response.
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Introduction
Anti-Mullerian hormone (AMH) also known as Mullerian Inhibiting Substance (MIS) is
a homodimeric disulfide-linked glycoprotein belonging to the transforming growth factor-β
family, with a molecular weight of 140 kDa (Josso et al., 2001). In the male, AMH is expressed
exclusively in the gonads, and causes regression of the Mullerian ducts during male fetal sexual
differentiation (Jost et al., 1972). In the female, AMH is expressed within the granulosa cells of
follicles (Vigier et al., 1984; Takahashi et al., 1986; Monniaux et al., 2008). Secretion of AMH
is greatest in 2 to 5 mm follicles but smaller follicles also may contribute to serum AMH
concentration (Van Rooij et al., 2002). Expression of AMH decreases as follicles grow and
enlarge; expression is essentially lost when follicles reach 8 mm diameter or larger (Weenen et
al., 2004).
In the ovary, AMH has an inhibitory effect on primordial follicle recruitment as well as
on the responsiveness of growing follicles to follicle stimulating hormone (FSH) (Visser et al.,
2006). Anti-Mullerian hormone concentration can be assessed in serum, but the relative
contribution to the different follicle classes to the final serum concentration is unclear (Van Rooij
et al., 2002). A single measurement of AMH concentration in serum is a useful tool to determine
the size of the ovarian reserve of follicles in cattle (Ireland et al., 2008). Cattle that have low
follicle numbers have diminished ovarian function, poor oocyte quality and suboptimal fertility
(Ireland et al., 2009).
Anti-Mullerian hormone has also been classified as a good predictive marker of the
ovarian response to follicular stimulation for oocyte retrieval and in vitro embryo production
(Muttukrishna et al., 2004; Muttukrishna et al., 2005). Anti-Mullerian hormone has also been
classified as an endocrine marker that could help predict superovulatory responses administered
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to cows for embryo production (Rico et al., 2011). The present study was conducted to further
investigate the use of AMH and/or follicle counts as a predictor of subsequent superovulatory
response and embryo production in beef cows.
Materials and Methods
Animals and Superovulatory Treatments. A total of 79 cows, including 31 Angus, 2
Chianina, 10 Polled Hereford, 1 Maine-Anjou, 15 Shorthorn, 3 Simmental, and 17 crossbred of
various breeds were housed at the Food Animal Veterinary Services donor care facility located in
Rensselaer, Indiana. The embryo donors ranged from yearling heifers to 13 year old cows.
Donor body condition (BCS; 1 to 9 scale; Wagner et al., 1988) ranged from 4 to 8 and averaged
about 6. The cows were superovulated for in vivo embryo production, with embryos recovered
between April 28 and July 10, 2014. A total of 99 embryo collections were performed, with 20
of 79 donor cows collected twice. Depending upon scheduling, client preference and donor
history, superovulatory treatment was initiated either during the luteal phase of cow's natural
estrous cycle, or after insertion of a progesterone controlled internal drug release (CIDR) device.
Cows that were superovulated based on their natural cycle had superovulatory treatment
initiated between day 8 and 12 of the estrous cycle. Cows received twice daily (10 to 12 hours
apart), decreasing doses of porcine follicle stimulating hormone (FSH; Follitropin-V, Bioniche
Animal Health, Belleville Ontario CA) over 4-day period. The cows were injected (i.m) with 50
mg (NIH units) of FSH twice daily the first 2 days, then 40 and 30 mg twice daily on days 3 and
4, respectively. On the morning of the fourth day of FSH treatment, cows received an injection
of 2.5 cc (~ 312 µg) of Cloprostenol (Estrumate, Merck Animal Health, Summit, NJ) to induce
luteal regression. After Cloprostenol treatment, cows were observed for onset of estrus.
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Timing of insemination after detected estrus depended on the number of straws and type
of frozen-thawed semen used. When a single straw of semen was used, insemination occurred
12 to 16 hours after detected estrus. When multiple straws of semen were used, insemination
occurred within 12 hours of detected estrus, and again 6 to 8 hours later. When X- or Y-sorted
semen was used, insemination occurred 16 and again at 24 hours after detected estrus, with 3 to 6
straws of semen used in total, depending on sperm concentration per straw.
Cows superovulated regardless of the day of the estrous cycle, received a 1.38 g
progesterone insert (EAZI-Breed CIDR; Zoetis, Florham Park, NJ) of day 0, in conjunction with
an injection (i.m.) of 2.5 mg estradiol 17 beta and 50 mg of progesterone. On day 4,
superovulatory treatment was initiated following the same 4-day, descending dose protocol used
for cows during their natural cycle. On the morning of the fourth day of FSH treatment, the
CIDR was removed at the time of Cloprostenol injection. Insemination of cows after detected
estrus depended on the type and number of straws of semen to be used, as described previously.
Ultrasonography and Blood Collection. Before the initiation of superovulation,
ultrasonography (Aloka 500 V with 5.0 MHz linear transducer; Corometrics, Wallingford, CN)
was used to scan the ovaries of each donor to record the number of 3 to 5 mm follicles present.
Concurrent with ultrasonography, a 10 mL blood sample was collected via tail vein from each
cow, using a BD Vacutainer SS Plus Blood Collection Tube, (Ref. No. 367985, Becton, Dickson,
Franklin Lakes, NJ). Blood tubes were inverted several times to mix, and then allowed to clot
for 30 minutes to 1 hour at room temperature. After clotting, the tubes were held on ice until
centrifugation at 1,000 g for 10 minutes. Recovered serum was placed in 5 mL polypropylene
tubes and stored in a chest freezer at -15 to -20 C until analysis for Anti-Mullerian hormone
(AMH).
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Embryo Recovery and Evaluation. Non-surgical embryo recoveries were performed ~
day 7 of the subsequent estrous cycle, using a Foley catheter and ViGRO complete flush medium
(ViGRO™, Bioniche Animal Health, Pullman, WA). At the time of embryo collection, the
ovaries of donor cows were palpated to estimate the number of corpora lutea (CL) present on
each ovary. Recovered flush medium was filtered through a filter to reduce medium volume.
The flush medium was then searched, using a stereomicroscope to recover embryos. Recovered
embryos were evaluated for stage of development (morula, early blastocyst or blastocyst) and
morphological quality (grade 1, 2, degenerate or unfertilized), using standards established by the
International Embryo Transfer Society (IETS Manual, 3rd Ed., 1998).
Analysis of Serum Anti-Mullerian Hormone. Serum samples were removed from
frozen storage and thawed over night at 4 C. A 500 µL aliquot of serum was removed for each
tube and pipetted into cryogenic vials (Sumitomo Bakelite, Japan) and then re-frozen (-20 C).
The serum samples were shipped on dry ice over night to the Texas A&M Veterinary Diagnostic
Laboratory at College Station, TX. The diagnostic laboratory used a bovine AMH enzymelinked immunosorbent assay kit (Bovine AMH ELISA AL-114; Ansh Labs, Webster, TX) to
determine AMH concentration (ng/mL) in duplicate samples, following the assay kit
manufacture’s recommended procedures. The AMH assay had an analytical sensitivity of 0.011
ng/mL.
Statistical Analysis. Analysis was performed, using JMP Pro 10.0.0 statistical software
(SAS Institute, Inc.). Variables considered in the analysis were embryo donor breed,
superovulation protocol, AMH concentration, follicle and corpus luteum number, total,
transferable, degenerate embryos, and unfertilized ova. Superovulation protocol had no effect (P
 0.293) on number of corpora lutea, or the number of total, transferrable, degenerate embryos or
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unfertilized ova, so was removed from the analysis. There were no breed differences (P = 0.321)
for serum AMH concentration. Frequency distribution was used to assign AMH concentration
measured in serum samples to quartiles. Analysis of variance was then used to make
comparisons between AMH quartiles for number of 3 to 5 mm follicles, number of corpora lutea
at embryo collection, number of embryos recovered, and the percentages of transferrable and
degenerate embryos, and unfertilized ova. Percent transferrable embryos were defined as the
portion of total embryos recovered that were of grade 1 or 2 morphological quality. Percent
degenerate embryos were defined as the portion of total embryos recovered that exhibited limited
cleavage and/or were of poor morphological quality. Percent unfertilized ova were the portion of
all recovered embryos/structures that exhibited no cleavage.
Frequency distribution was also used to assign follicle counts to quartiles. Analysis of
variance was then used to make comparisons between follicle quartiles and number of corpora
lutea at embryo collection, number of embryos recovered, and the percentages of transferrable
and degenerate embryos, and unfertilized ova. Multivariate analysis was used to determine any
correlations between AMH concentrations and number of 3 to 5 mm follicles, number of corpora
lutea at embryo collection, number of embryos recovered, and the percentages of transferrable
and degenerate embryos, and unfertilized ova. All values are expressed as t h e mean ± SEM.
Statistical differences were considered significant where P < 0.05.
Superovulation and embryo recovery was performed twice on 20 of 79 donor cows
included in the study. To evaluate within donor, the repeatability of AMH, follicle and CL
counts, and embryos recovered per superovulation, the distribution of the variables were
assigned to quartiles and compared in a contingency table generated through Chi square analysis.
Results
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Measure of AMH and its predictive value for superovulatory response. AntiMullerian hormone measured in serum samples ranged from 0.013 to 0.898 ng/mL, with a mean
of 0.293 ng/mL. The distribution of AMH concentrations was divided into quartiles (AMH Q1
through Q4, with Q1 the lowest and Q4 the highest ng/mL) for analysis. The range of AMH
concentrations within each quartile are presented in Table 1. The assay failed to detect AMH in
3 serum samples, possibly due to either assay failure or concentrations below detection limits.
Donor cows in AMH Q4 had a greater (P < 0.001) number of 3 to 5 mm follicles at the start of
superovulation than did donors in either Q1 or Q2. Cows in AMH Q3 were intermediate for
mean number of follicles. At the time of embryo collection, cows in AMH Q3 and 4 had more
palpable CL than cows in AMH Q1 (P < 0.001). The mean number of CL for cows in AMH Q2
was intermediate and similar (P > 0.10) to those in both AMH Q1 and 3. The mean number of
embryos recovered for donor cows in AMH Q4 was greater (P < 0.001) than those recovered
from cows in either AMH Q1 or 2, but similar to that of AMH Q3. The percentage of recovered
embryos that were classified as transferrable, degenerate or unfertilized were similar (P  0.275)
across AMH quartiles. Multivariate analysis (Table 2) indicated that AMH was positively
correlated (P < 0.001) with mean follicles (r = 0.458), CL (r = 0.452) and embryos recovered (r =
0.430).
Predictive value of follicle number for superovulatory response. The number of 3 to
5 mm follicles counted on the ovaries of donor cows ranged from 5 to over 30, with a mean of
16. In order to determine if follicle counts at the start of superovulation might be predictive of
subsequent superovulatory response, the distribution of follicle counts were also divided into
quartiles (F Q1 through Q4, with Q1 the lowest and Q4 the highest) for analysis (Table 3).
Donor cows with higher follicle counts (F Q3 and 4) at the start of superovulation had more (P <
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0.001) palpable CL at embryo collection than donor cows in F Q1 or 2. More embryos were
recovered from cows with the highest follicle counts (F Q4) as compared with cows having
lower (F Q1 and 2) follicle counts (P < 0.001). The number of embryos recovered from donors
in F Q3 was intermediate and similar (P > 0.10) to that of donors in F Q1, 2 and 4. The
percentage of transferable embryos and unfertilized ova were similar (P  0.688) across follicle
count quartiles. The mean percentage of degenerate embryos was greater for donor cows in F
Q3 than any other follicle quartile (P = 0.002).
As was noted for AMH, mean follicles at the start of superovulation was positively
correlated (P < 0.001; Table 2) with mean CL (r = 0.556) and mean embryos (r = 0.423) but not
percentage of viable or degenerate embryos, or unfertilized oocytes (P  0.153). Other
correlations noted were positive correlations between mean CL and embryos recovered (r =
0.887; P < 0.001), and between embryos collected and degenerate embryos (r = 0.236; P =
0.021). As might be expected, a significant negative correlation (r = -0.931; P < 0.001) existed
between percentage viable and percent unfertilized embryos.
Repeatability within donors. Twenty of the donor cows used for the study were
superovulated and had embryo collections performed twice. To evaluate repeatability within
donor, AMH, follicle and CL counts and embryos recovered per collection were assigned to
quartiles for comparison within donor cows (Table 4). Only a single serum AMH measure was
available for one donor. Of the remaining 19 donors, 17 of 19 were found to be within the same
or an adjacent quartile for AMH, from one superovulation and embryo collection until the next.
For follicle counts, 18 of 20 cows were found to fall within the same or an adjacent quartile from
one collection to the next. At embryo collection, 16 of 20 donors were within the same or an
adjacent quartile for CL number, as were 18 of 20 donors for total embryo production.
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Discussion
Since the development of cattle superovulation and non-surgical embryo recovery in the
1970s, the unpredictability of the superovulatory response has remained a major obstacle. The
variability between animals in ovulatory response to FSH-induced superovulation is mainly due
to differences in ovarian activity at the time of treatment (Rico et al., 2009). Cows may ovulate
from 0 to 40 follicles following a 4 to 5 day treatment with FSH (Rouillier et al., 1996). An
average response to superovulation is 12 total and 6 transferable embryos, although 15 to 20
percent of donors will not respond to superovulation (Hasler, 2010). Cattle that are
superovulated after reaching age 8 to 10 tend to produce fewer embryos. Individual variation
among females remains the largest and least understood variable in superovulation. While some
females consistently produce large numbers of embryos, other females of similar age, breed,
weight, management, and etc. perform poorly.
The purpose of superovulation is to stimulate a number of small antral follicles to grow
and mature, resulting in multiple ovulations. Therefore, the pool of small antral follicles
available for stimulation should dictate the superovulatory response. Previous studies have
shown a positive correlation between small antral follicle number and serum concentrations of
AMH (Visser et al., 2006; Ireland et al., 2008). Furthermore, diminished ovarian reserves of
follicles have been observed in cattle exhibiting low AMH concentrations (Ireland et al., 2010).
The present study was conducted to investigate whether AMH and/or antral follicle numbers
could be used as a predictor of superovulatory response and embryo production in donor cows.
Assay of AMH in the serum of 79 embryo donor cows in the present study found that
AMH ranged from 0.013 to 0.898 ng/mL. Although different ranges have been reported in
previous years. Souza et al. (2015) reported an AMH range from 0.00001 to 0.3743 ng/mL,
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while Monniaux et al. (2010) reported AMH concentrations to range from 0.0011 to 0.5312
ng/mL and Rico et al. (2009) reported ranges in three different sessions, (T0) first injection of
FSH, (TE) time of estrus and (TL) 7 days after estrus. Anti-Mullerian hormone concentrations
ranged from 0.025 to 0.228 ng/mL at T0, 0.049 to 0.359 ng/mL at TE and 0.026 to 0.212 ng/mL
at TL, respectively. Compared to cows with lower AMH, cows with high AMH concentrations in
serum had the highest follicular counts and ovulatory responses to superovulatory treatment.
These results agree with data obtained from (Ireland et al., 2008; Rico et al., 2009; Ireland et al.,
2010). Ireland et al. (2008) reported that AMH concentrations were approximately 6 and 2 fold
greater in animals with higher follicular counts (39.61 ± 2.3) compared with low follicle counts
(11.95 ± 1.2). Rico et al. (2009) indicated that cattle with high numbers of 3 to 7 mm follicles
before the superovulatory treatment had higher AMH concentrations and resulted in a higher
ovarian response. Furthermore, Ireland et al. (2010) classified follicle counts ≥ 3 mm into low (≤
15), intermediate (16 to 24) and high (≥ 25) categories. Anti-Mullerian hormone concentrations
were found to be 2 and 6 folds higher for cattle within the intermediate or high group.
A difficulty is using AMH as a predictor of superovulatory response is in how to classify
a donor cow by AMH. Studies differ in the reported cut-off values for identifying AMH
concentration as low, moderate or high. Rico et al. (2012) reported AMH concentrations ranging
from 0.005 to 0.244 ng/mL where cattle below 0.087 ng/mL identified as poor responders to
superovulation and having less than 15 large follicles near the time of estrus. Guerreiro et al.
(2014) classified AMH into high and low categories with 0.2 ± 0.01 ng/mL being low and 0.4 ±
0.02 ng/mL being high. Ribeiro et al. (2014) classified AMH into three categories, where low
ranged from 0.01 to 0.14 ng/mL, intermediate 0.141 to 0.45 ng/mL and high 0.451 to 3.19800
ng/mL. Differences in cut-off points between studies may be related to several factors, including
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differences in measure of superovulatory response (large follicle counts near estrus; Rico et al.,
2012 versus CL counts on the day of embryo collection; Souza et al., 2015), different AMH
assays, and different methods used to collect plasma as reported by Rico et al. (2012).
Therefore, cows were classified into quartiles of circulating AMH concentration rather than by
specific concentrations in blood. Donor cows within the highest quartile (Q4) for AMH had
more 3 to 5 mm follicles present in their ovaries at the start of superovulation than did donors in
the lowest quartile (Q1). Overall, mean follicle number at the start of superovulatory treatment
was positively correlated (r = 0.458; P < 0.001) with AMH. Rico et al. (2009) reported a similar
correlation (r = 0.79; P < 0.001) between AMH and number of antral follicles detected via
ultrasonography before the start of superovulatory treatment.
Donor cows within Q4 for AMH had more CLs and produced more embryos at embryo
collection than donor cows in the lowest 2 quartiles (Q1 and 2). As might be expected, mean
corpora lutea was positively correlated (r = 0.887; P < 0.001) with mean embryos recovered.
However the number of embryos or structures classified as transferrable, degenerate or
unfertilized were similar among AMH quartiles and were not correlated with AMH. Souza et al.
(2015), who divided superovulated dairy cows into quartiles based on circulating AMH, reported
results similar to the current study in that total number of embryos recovered was greater for
donors in the highest AMH quartile versus the lowest. Also in agreement with the current study,
Souza et al. (2015) reported that AMH quartile had no effect on the percentage of transferrable
or fertilized embryos.
Fertilization rate can vary depending on semen quality and concentration, insemination
timing and technique, and inherit fertility of the bull. Embryo morphological quality after
fertilization can be influenced by the same factors, as well as uterine environment. Although
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superovulating cattle does produce more offspring from superior genetics, repeated treatment
with high doses of gonadotropins can alter follicular development, oocyte maturation, ovulation
and sperm transport. These abnormalities may disrupt the normal fertilization and/or embryo
development process to result in an increased number of unfertilized oocytes and poor quality
embryos (Kafi and McGowan, 1997). Perhaps, it is not surprising that level of circulating AMH
had little measurable effect on fertilization rate or embryo morphological quality.
Assay for AMH is relatively expensive and limited in availability to most embryo
transfer practitioners. However, many practitioners have access to ultrasonography and often
evaluate ovarian structures before superovulation. As an alternate to AMH, the number of 3 to 5
mm follicles present in the ovaries at initiation of superovulatory treatment was evaluated as a
predictor of superovulatory response. As with serum AMH, donors were assigned to quartiles
for comparison. Results suggest that follicle counts would be of value for predicting subsequent
superovulatory response. Donor cows in the highest quartile for 3 to 5 mm follicles also had
more embryos at collection than cows in the lowest two quartiles. In a previous study using
ultrasound to determine antral follicle count, Ireland et al. (2007) reported that cows with high
follicle numbers also had more embryos recovered and more transferable embryos.
As previously stated, there is great donor-to-donor variation in superovulatory response
and embryo production (Kafi and McGowan, 1997). Empirical evidence suggests that there is
more consistency within donors. A limited number of donors in the present study were
superovulated and embryo recoveries performed twice. While AMH concentration varied within
donor, 17 of 19 donors were categorized within the same or adjacent quartile for AMH prior to
superovulation. Likewise follicle counts within donors were within the same or an adjacent
quartile at subsequent superovulations. These results confirm that there is some consistency
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within donors, and that at least over a short (~ 3 month) period of time, a single AMH assay can
be used as a potential predictor of superovulatory response.
Currently, embryo donor history such as breed, age, weight, BCS, and parity are used to
adjust the superovulatory regimen in an effort to improve embryo production. While
improvements have been made in hormonal treatment and synchronization protocols (Hasler,
2014) the mean number of transferrable embryos recovered per donor animal has remained
relatively constant for the past 40 years. Many commercial embryo transfer (ET) programs
across the country are limited in options because donors and service sires are often chosen by the
owner, and many times procedures are done on farm and mostly out of the control of
practitioners (Hasler, 2010). The ability to make adjustments to superovulatory regimens based
on predicted superovulatory response of individual donors would be of great benefit to the ET
industry moving forward. The study confirms that relative AMH level is positively correlated
with number of small antral follicles in the ovaries of cows and might be used to either predict
superovulatory response or possibly adjust superovulatory regimen to improve superovulatory
response. Antral follicle counts at the initiation of superovulatory treatments might be a more
practical alternate to AMH for ET practitioners to use in predicting superovulatory response.
Further study is needed to determine the effectiveness of using either AMH assay or follicle
counts to adjust superovulatory regimens for improved response.
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Table 1. Quartile categorization of AMH concentrations as predictor of superovulatory
outcomes.
Quartile of AMH concentration
Item

Q1

Q2

Q3

Q4

AMH, ng/mL

0.013 - 0.068

0.069 - 0.263

0.264 - 0.363

0.364 - 0.898

No. of donors

26

22

24

24

No. of follicles

13.46 ± 0.91b

14.95 ± 0.98b

16.79 ± 0.94ab

19.33 ± 0.94a

0.001

No. of CL

11.62 ± 1.54c

13.68 ± 1.67bc

17.58 ± 1.60ab 20.54 ± 1.60a

0.001

9.77 ± 1.76b

9.36 ± 1.91b

15.50 ± 1.83ab 20.13 ± 1.83a

0.001

No. of embryos

P-value

Transferable %

69.32 ± 6.62

57.06 ± 7.08

58.75 ± 6.62

51.05 ± 6.62

0.275

Degenerate %

5.52 ± 2.52

7.89 ± 2.69

9.40 ± 2.52

9.87 ± 2.52

0.614

Unfertilized %

25.16 ± 6.73

35.06 ± 7.19

31.85 ± 6.73

39.09 ± 6.73

0.519

a,b,c

Numbers within rows with unlike superscripts differ (P  0.05).

32

Table 2. Correlations between AMH, follicle counts, and embryo production of
superovulated donor cows.
Variable 1
Variable 2
Correlation
P-values
Anti-Mullerian hormone

Mean # follicles

0.458

0.001

Mean # corpora lutea

0.452

0.001

Mean # embryos

0.430

0.001

-0.126

0.231

Percent degenerate

0.195

0.061

Percent unfertilized

0.052

0.621

Mean # corpora lutea

0.556

0.001

Mean # embryos

0.423

0.001

Percent # viable

-0.037

0.724

Percent degenerate

0.147

0.153

Percent unfertilized

-0.018

0.857

0.887

0.001

-0.008

0.942

Percent degenerate

0.191

0.063

Percent unfertilized

-0.064

0.539

Percent viable

0.011

0.919

Percent degenerate

0.236

0.021

Percent unfertilized

-0.098

0.341

Percent degenerate

-0.184

0.073

Percent unfertilized

-0.931

0.001

Percent degenerate

-0.188

0.067

Percent viable

Mean # follicles

Mean # corpora lutea

Mean # embryos
Percent viable

Mean # embryos

Percent viable

Percent unfertilized
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Table 3. Quartile categorization of follicle counts as a predictor of superovulatory response
and embryo production.
Quartile of follicle counts
Item

Q1

Q2

Q3

Q4

P-value

No. of donors

26

35

20

18

Follicle range

5 - 12

13 - 17

18 - 20

21 - 30

10.65 ± 1.40b

13.51 ± 1.20b

19.15 ± 1.59a

23.33 ± 1.68a

0.001

9.62 ± 1.79b

11.57 ± 1.55b

16.50 ± 2.04ab 20.00 ± 2.16a

0.001

64.77 ± 5.63

54.51 ± 7.53

0.716

No. of CL
No. of embryos
Transferable %
Degenerate %
Unfertilized %
a,b

58.20 ± 6.44
4.82 ± 2.23b
36.99 ± 6.44

6.71 ± 1.95b
28.53 ± 5.63

17.09 ± 2.61a
28.39 ± 7.54

Numbers within rows with unlike superscripts differ (P  0.05).
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58.46 ± 7.97
5.38 ± 2.76b
36.16 ± 7.97

0.002
0.688

Table 4. Repeatability of embryo donors for AMH, follicle and corpus luteum counts and
embryo production.
Superovulation and Superovulation and Superovulation and Superovulation and
embryo collection
embryo collection
embryo collection
embryo collection
1
2
1
2
1
2
1
2
Embryo
AMH
AMH
Follicle Follicle
CL
CL
Embryo Embryo
Donor
quartile quartile quartile quartile quartile quartile quartile quartile
1
1
1
1
2
1
2
3
3
2

3

4

2

3

2

3

3

4

3

3

4

2

3

2

2

2

2

4

4

4

2

3

2

3

3

3

5

3

4

1

2

1

2

1

2

6

1

1

1

2

1

1

1

1

7

1

3

2

3

3

3

3

4

8

1

3

2

3

1

2

1

2

9

4

4

4

4

4

4

4

4

10

*

2

2

3

2

2

1

2

11

1

1

2

2

1

1

1

1

12

3

4

3

3

2

4

3

4

13

1

1

1

2

1

2

2

2

14

2

2

1

2

1

2

1

1

15

3

4

3

4

3

4

2

4

16

3

4

1

4

4

4

3

4

17

3

4

4

4

4

4

4

4

18

2

2

3

4

1

4

1

1

19

1

2

1

1

1

3

1

3

20

1

1

2

4

2

4

3

3

*

Anti-Mullerian hormone could not be detected in one blood sample from donor 10.
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CHAPTER 3: CONCLUSION
Research presented in this thesis examined physiological variations and clinical
applications of Anti-Mullerian hormone (AMH) in various breeds of cattle. In addition, antral
follicle counts (AFC) were evaluated via ultrasonography to evaluate the correlation among
AMH, AFC, total number of corpora lutea (CL), total number of embryos recovered in vivo, and
the percentage of unfertilized oocytes. The primary goal of this review was to focus on AMH
expression in the cow; nevertheless, some of the derived information in this document was
accommodated from other species but not limited to humans, goats and rodents.
Anti-Mullerian hormone is one of the most important hormones in reproductive
physiology because of the role the hormone plays in sexual differentiation during fetal
development. To date, AMH has been compared to AFC which represents the total number of
follicles detected using ultrasonography although, is it possible a large proportion of atretic
follicles, do not contribute to circulating AMH concentrations. Therefore, one could theorize
that AMH concentrations are a reflection on the number of follicles being recruited in each
follicular wave, although it would be difficult to detect as new recruited follicles are being
overlapped by larger regressing follicles. Nevertheless, AMH appeared to be a useful tool on the
prediction of total number of antral follicles and embryos in the cow.
The variation in AMH concentration and AFC in cows tended to reflect ovarian reserve
and follicular function. Results in this study indicated that follicle and embryo numbers are
impaired with low AFC or low AMH concentration and that higher AFC and AMH resulted in
higher follicle and embryo numbers, respectively. Therefore, measuring the concentration of
AMH as well as determining the number of antral follicles should be an essential part in the
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reproductive examination of cattle as it provides valuable information about superovulatory
response and could help embryo transfer practitioners predict how well a cow will respond to
superovulatory treatments throughout her reproductive lifespan.
In conclusion, circulating AMH concentration and AFC were highly associated with
superovulatory response and the total number of embryos produced in individual cows. If
commercial AMH assays were to become available it could become a valuable practical method
for improving the efficiency of multiple ovulation and embryo transfer (MOET) programs in
beef cattle herds not only in America but across the world.
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